Fairfax Financial Holdings’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-21,158
Closed -$64.1K 32
2024
Q4
$64.1K Buy
+21,158
New +$64.1K ﹤0.01% 31